b'I N T R O D U C T I O NMultiparametric Flow Cytometry PanelsMultiparametric Flow Cytometry (MFC) is a diverse technology platform with many clinical applications. One application of MFC is the ability to evaluate individual cells in suspension for the presence and absence of specific antigens and can be used to characterize disease in a clinical setting. The technology plays a critical role in the evaluation of peripheral blood and bone marrow samples for screening, diagnosis, prognosis and classification of many hematolymphoid neoplasia, including AML. Immunophenotyping white blood cells allows for the identification of normal and abnormal cell phenotypes which can identify normal cell populations, lymphoid neoplasia, plasma cell dyscrasia, acute leukemia and other disease of various cell lineages. MFC in the clinical setting now allows for 12 parameters to be simultaneously measured and analyzed and can provide rapid and actionable results forclinical decision making.Another application of MFC includes measurable residual disease (MRD) testing. MRD testing by MFC can detect disease levels down below 10 -4and can provide information about remission status, outcome prediction, early identification of relapse and as a potential surrogate end point to accelerate drug testing and approvals.MULTIPARAMETRIC FLOW CYTOMETRY PANELS LabPMM Services Catalog 2021|57'